Filtered By:
Drug: Temodar
Countries: Italy Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 20 results found since Jan 2013.
Italian Guidelines for the Management of Prolactinomas
CONCLUSION: The present GL is directed to endocrinologists, neurosurgeons, and gynecologists working in hospitals, in territorial services or private practice, and to general practitioners and patients.PMID:37171003 | DOI:10.2174/1871530323666230511104045
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - May 12, 2023 Category: Endocrinology Authors: Renato Cozzi Renata Simona Auriemma Ernesto De Menis Felice Esposito Emanuele Ferrante Giuseppe Iat ì Diego Mazzatenta Maurizio Poggi Roberta Rud à Fabio Tortora Fabio Cruciani Zuzana Mitrova Rosella Saulle Simona Vecchi Michele Basile Paolo Cappabianca Source Type: research
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3 < sup > rd < /sup > -line treatment
CONCLUSION: Everolimus was the most frequently used therapeutic option in the third-line setting. The most important factors for decision-making included Ki-67, rate of progression, functionality and tumour burden; since this decision is based on multiple factors, it highlights the need for a multidisciplinary assessment.PMID:33776367 | PMC:PMC7968134 | DOI:10.3748/wjg.v27.i10.976
Source: World Journal of Gastroenterology - March 29, 2021 Category: Gastroenterology Authors: Angela Lamarca Mauro Cives Louis de Mestier Joakim Crona Francesca Spada Kjell Öberg Marianne Pavel Teresa Alonso-Gordoa Source Type: research
